CC
CC
NYSE · Chemicals

Chemours Co/The

$17.70
-1.24 (-6.55%)
As of Mar 22, 9:59 PM ET ·
Financial Highlights (FY 2026)
Revenue
5.71B
Net Income
-379,274,091
Gross Margin
15.5%
Profit Margin
-6.7%
Rev Growth
-5.1%
D/E Ratio
16.56
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 15.5% 15.5% 63.7% 63.7%
Operating Margin -1.2% -1.1% 17.2% 16.6%
Profit Margin -6.7% -6.3% 14.1% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.71B 6.01B 1.47B 1.14B
Gross Profit 886.26M 933.79M 935.67M 729.26M
Operating Income -67,910,169 -64,396,957 252.18M 189.87M
Net Income -379,274,091 -359,653,020 207.35M 138.00M
Gross Margin 15.5% 15.5% 63.7% 63.7%
Operating Margin -1.2% -1.1% 17.2% 16.6%
Profit Margin -6.7% -6.3% 14.1% 12.1%
Rev Growth -5.1% -5.1% +3.4% -3.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.19B 1.19B 238.65M 224.84M
Total Equity 71.56M 71.56M 1.62B 1.46B
D/E Ratio 16.56 16.56 0.15 0.15
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 302.63M 302.92M 357.73M 261.35M
Free Cash Flow 156.58M 99.38M